Medical Imaging

Esaote S.p.A. is a global medical imaging manufacturer founded in the early 1980s, headquartered in Italy with significant operations in the United States (Fishers, IN). The company specializes in ultrasound systems, magnetic resonance imaging (MRI), and healthcare IT solutions. Their product portfolio includes advanced ultrasound platforms such as the MyLab series (MyLab E85 GTS, MyLab C30 GTS) featuring proprietary technologies like PAM (Photoacoustic Microscopy) for precision imaging across multiple clinical applications including cardiology, urology, and interventional radiology. Esaote also develops intraoperative MRI systems, exemplified by the I-Genius platform for neurosurgery. The company offers comprehensive healthcare IT and enterprise imaging solutions integrated with clinical workflows for prevention, diagnosis, therapy, and follow-up. Esaote serves hospitals, diagnostic imaging centers, and specialty practices globally. The company holds relevant regulatory certifications and maintains robust R&D capabilities focused on clinical needs and market trends. Esaote emphasizes customer care, technical support, and equipment performance optimization. The organization has achieved UNI/PdR 125:2022 gender equality certification and maintains commitment to sustainability and ESG principles. Recent strategic partnerships, such as with Schiller Americas for cardiology imaging expansion, reflect the company's growth trajectory in the North American market.

MinXray, Inc. (established 1967) is a leading manufacturer of portable, compact, and mobile X-ray equipment and digital radiography systems. Based in Northbrook, Illinois, the company specializes in field-transportable digital imaging solutions for medical, veterinary, military, and global health applications. MinXray's lightweight, rapidly deployable systems are engineered for onsite imaging in environments where conventional large-format units are impractical—including nursing homes, emergency response, prisons, remote clinics, cruise ships, and military field operations. The company's IMPACT wireless system combines digital radiography with portable ultrasound technology, serving general medical, emergency care, sports medicine, and facility safety markets. MinXray also supports companion animals, equine/large animal, mixed animal, and zoo/marine veterinary imaging. The company has demonstrated innovation through collaborations including NASA space-based medical X-ray imaging and AI-powered tuberculosis screening in Nepal. With a commitment to responsive customer support and rapid equipment deployment, MinXray enables diagnostic imaging in 90+ countries.

RefleXion Medical develops biology-guided radiotherapy (BGRT) systems for cancer treatment. The company's flagship product, the RefleXion X1 machine with SCINTIX autonomous radiotherapy, combines PET (positron-emission tomography) imaging with linear accelerator (LINAC) radiation therapy to enable real-time tumor tracking and treatment delivery. SCINTIX detects biological signals emitted by cancer cells after radiopharmaceutical injection and uses this information to autonomously guide radiation beams to tumors in motion, potentially reducing dose to surrounding healthy tissue. The system is FDA-cleared for treatment of lung and bone tumors, including primary and metastatic disease at any stage. In addition to SCINTIX therapy, the RefleXion X1 platform delivers conventional radiotherapy modalities including SBRT (stereotactic body radiation therapy), SRS (stereotactic radiosurgery), and IMRT (intensity-modulated radiation therapy) for solid tumors throughout the body. The platform is designed to fit standard radiotherapy vaults with minimal shielding modifications and is compatible with third-party immobilization devices and existing contouring tools. Founded in 2009 by Sam Mazin, Ph.D. and Akshay Nanduri, RefleXion has secured over $400 million in venture financing and employs more than 250 people. Leadership includes Todd Powell (President and CEO, formerly of Elekta) and Martyn Webster (CFO). SCINTIX therapy has achieved Medicare reimbursement through multiple Medicare Administrative Contractors (MACs), supporting adoption in freestanding cancer centers and hospital outpatient departments. The company targets oncology departments, cancer centers, and radiation therapy facilities.

MRIaudio manufactures and distributes MRI-compatible audio and video entertainment systems designed to reduce patient anxiety, improve satisfaction, and minimize scan abortions during magnetic resonance imaging procedures. The company's core product portfolio includes MRI-conditional headphones with 29 decibels of noise cancellation, a proprietary Sonic Transducer for high-fidelity audio delivery, a digital amplifier for multimedia integration, iPad-based control and entertainment management, and the MRItv 4k Pro Video Suite for patient video selection during scans. Products are non-magnetic and designed for safe operation in MRI environments. MRIaudio holds FDA 510(k) clearance and emphasizes patient experience optimization through audio-visual distraction, which reduces claustrophobia-related anxiety (reported in 42% of MRI patients), minimizes involuntary patient movement that causes scan repeats (10–15% of scans), and can reduce sedation requirements (14% of patients). The company serves imaging centers, hospital MRI departments, specialty clinics, and major healthcare systems including GE, Siemens, Fujifilm, Philips, and institutions like UCSD Medical Center and St. Jude Hospital. Key operational features include iPad-based remote troubleshooting via FaceTime, direct technologist-to-patient microphone override capability, music streaming integration, 30-day satisfaction guarantee, and 1-year limited warranty. MRIaudio emphasizes rapid customer service response and equipment installation support.

Data Spectrum Corporation is the world's leading supplier of high-quality SPECT phantoms and molecular imaging quality control devices. Founded in 1981 and headquartered in Durham, North Carolina, the company manufactures phantoms and inserts for acceptance testing, quality control, and research validation of Single-Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), Magnetic Resonance Imaging (MRI), and combined medical imaging systems. Data Spectrum phantoms are the accreditation standard used by the American College of Radiology (ACR) for all nuclear and molecular imaging system evaluations. The company's product portfolio includes the Jaszczak Phantom and related accessories designed to enable medical imaging professionals to evaluate image resolution, validate system performance, and ensure imaging accuracy. All products are designed and manufactured in the United States to meet strict quality control guidelines. Data Spectrum serves the medical imaging profession globally, providing phantoms and quality assurance tools essential for clinical imaging departments, research institutions, and imaging equipment manufacturers seeking regulatory compliance and performance validation.

Coghlin Companies, Inc. is a fourth-generation contract manufacturing and engineering services company (founded 1885) specializing in the design, engineering, and precision manufacturing of complex capital equipment and medical devices. Based in Westborough, Massachusetts, with ~480 employees and $159.9M annual revenue, the company serves medical life sciences, semiconductor, robotics, and industrial sectors. Core capabilities include product engineering, design for manufacturability (DFM), prototyping, printed circuit board assembly, total system integration, and global supply chain fulfillment. Notable achievements include manufacturing 10,000 ventilators during COVID-19. Coghlin operates both industrial (Columbia Tech) and medical (Cogmedix) divisions, providing end-to-end commercialization services from concept through scalable manufacturing and aftermarket support.

Oncovision is a Spanish-based medical imaging company specializing in innovative diagnostic and therapeutic imaging devices for oncology, radiology, surgery, and nuclear medicine. The company develops molecular imaging solutions focused on early cancer detection and treatment planning. Primary product lines include Mammi (breast PET imaging system for breast cancer diagnosis), Sentinella (intraoperative imaging system for surgical guidance), WProbe (portable probe device for accurate, practical imaging applications), and CaremiBrain (neuroimaging application for Alzheimer's disease diagnosis). The company serves surgeons, radiologists, oncologists, and nuclear physicians. Oncovision holds recognition as an innovative SME (PYME INNOVADORA) with validity through May 2027, indicating compliance with Spanish innovation standards. The company has received funding through Generalitat Valenciana's Fondos Plan Resistir Plus and is capitalized by Innvierte, an investment initiative of Spain's CDTI (Centro para el Desarrollo Tecnológico Industrial). The organization emphasizes innovation, commitment, excellence, and continuous improvement in molecular imaging technology for cancer diagnosis and treatment.

Spectrum Dynamics Medical is a specialized medical device manufacturer focused on personalized molecular imaging and nuclear medicine applications. The company develops high-definition, solid-state nuclear imaging technology using proprietary 360° CZT (Cadmium Zinc Telluride) detector technology. Their portfolio includes the D-SPECT Series, an advanced digital SPECT imaging system designed for cardiology applications featuring rapid myocardial perfusion imaging (scan times as fast as 2 minutes), dynamic imaging for flow reserve calculation, and emission-based attenuation correction; and the VERITON-CT Series, the first ring-shaped SPECT/CT hybrid system enabling comprehensive total-body 3D imaging with an 80 cm bore size for expanded procedural capabilities. CZT solid-state detectors provide superior sensitivity and energy resolution compared to traditional NaI detectors, eliminating the need for photomultiplier tubes and enabling higher count rates. Spectrum Dynamics serves hospitals, cardiology clinics, diagnostic imaging departments, and nuclear medicine centers globally, with R&D facilities in Haifa, Israel and regional offices across North America, Europe, and Asia-Pacific.

Healthcare Tech Solutions is a specialized medical imaging IT consulting and services firm serving healthcare organizations nationwide. The company provides comprehensive DICOM data migration services, PACS administration and support, VNA (Vendor Neutral Archive) consulting, and enterprise imaging management. Core service offerings include self-managed and full-service DICOM migrations, SCO-to-BTO and CTO-to-BTO breast imaging conversions, PACS system implementation advisory, and staffing solutions with vetted medical imaging professionals. The company also supplies diagnostic displays/monitors, media systems, and medical imaging hardware. Founded by former PACS administrators, Healthcare Tech Solutions addresses challenges in data integration during hospital mergers and acquisitions, legacy system conversions, and imaging workflow optimization. The firm offers strategic guidance, implementation project management, infrastructure design, and ongoing technical support to streamline operations and enhance patient care while reducing costs and operational disruptions.

eCential Robotics is a surgical robotics company specializing in an open, unified platform integrating 2D/3D imaging, real-time navigation, and robotic systems for bone surgery. Founded in 2009 and headquartered in Grenoble, France, with US operations in Franklin, Tennessee, the company serves orthopedic and neurosurgery markets with over 3,500 completed procedures. The platform is implant-agnostic, supporting third-party surgical app development and compatible with implants from multiple manufacturers, allowing surgeons to select the optimal technique and device for each patient. Key features include integrated imaging and navigation within a single interface, support for minimally invasive approaches, and multi-specialty surgical applications. With over 100 patents and approximately 105 employees, eCential Robotics focuses on digitalizing traditional surgical techniques to enhance patient safety, surgeon precision, and operational efficiency in the OR.

CorTechs Labs is a SaaS-based medical imaging software company specializing in AI-powered quantitative analysis of brain and oncological imaging. The company develops advanced algorithms for automated brain segmentation, volumetric analysis, and lesion quantification across MRI, CT, and PET modalities. Their solutions enable clinicians to detect and monitor neurodegenerative diseases (dementia, Alzheimer's, multiple sclerosis), brain tumors, and prostate cancer with improved diagnostic confidence and efficiency. CorTechs' flagship NeuroQuant® platform has processed over 2 million brain scans across 1,500+ medical institutions in 44 countries, providing radiologists with rapid, objective measurements for disease progression tracking and comparative analysis against normative databases. The company also offers OnQ™ Prostate for prostate MRI analysis and specialized tools for lesion surveillance and post-operative assessment. Solutions integrate with major OEM imaging platforms (GE, Siemens, Philips, Canon) and are supported by Category III CPT codes for reimbursement.

Viz.ai is an AI-powered care coordination platform that leverages over 50 FDA-cleared algorithms to analyze medical imaging data and detect suspected diseases in real time. The company's flagship product, Viz.ai One®, autodetects conditions across multiple therapeutic areas including neurovascular disease, vascular conditions, cardiac imaging, trauma, and general radiology. The platform integrates specialized suites—Viz Neuro, Viz Cardio, Viz Vascular, Viz Trauma, and Viz Radiology—designed to accelerate diagnosis, streamline clinical workflows, and facilitate faster treatment decisions in acute care settings. Deployed in over 1,700 hospitals and health systems across the U.S. and Europe, Viz.ai's technology processes CT scans, EKGs, echocardiograms, and other imaging modalities to deliver automated assessments and real-time alerts to clinicians via mobile and desktop devices. The platform also supports life sciences partnerships with pharmaceutical and medical device companies for clinical trial optimization and disease-specific research applications.

EyeCare Technologies is a specialized ophthalmic equipment distributor and service provider serving optometrists and ophthalmologists across the Gulf South. The company supplies a comprehensive range of diagnostic, imaging, and surgical equipment from trusted manufacturers including Meridian, Reichert, Haag-Streit, Olleyes, Volk, Keeler, and CSO Italia. Product offerings span autorefractors, visual field testers, tonometers, OCT systems, slit lamps, laser systems (SLT/YAG combo platforms), handheld retinal cameras, meibography systems, and modular exam lane furniture. Beyond equipment distribution, EyeCare Technologies provides full-service support including installation, staff training, maintenance, repairs, and practice consultation for independent providers, growing groups, and new-practice launches. The company emphasizes consultative sales, responsive technical support, and long-term partnership rather than transactional vendor relationships.

Convergent Imaging Solutions develops advanced image fusion and nuclear medicine software solutions for healthcare facilities. The company's flagship product, UniSyn MI™ software, provides comprehensive image fusion capabilities across multiple modalities including PET/CT, SPECT/CT, and PET/MR imaging. UniSyn MI supports local, remote, and hybrid deployment models with seamless PACS integration and configurable viewing and processing options. The software serves four primary clinical specialties: oncology (diagnosis, staging, recurrence detection, and treatment response evaluation), general nuclear medicine (planar, gated, and dynamic imaging analysis), cardiology (leveraging partnerships with Cedars-Sinai for cardiac processing), and neurology (neuroradiology imaging). The company also provides radiopharmaceutical dosimetry solutions for theranostic applications including metastatic neuroendocrine tumors, differentiated thyroid cancer, metastatic prostate cancer, and primary/metastatic liver disease. Convergent Imaging Solutions emphasizes workflow optimization, customizable solutions tailored to individual facility needs, and dedicated expert support. The company has received FDA 510(k) clearance for its MRT Dosimetry module. Based in Ottawa, Ontario, Canada, the company supports radiology and nuclear medicine professionals globally, serving as a workflow-optimized software provider for precision diagnostic imaging.

QMENTA is a cloud-based medical imaging AI platform founded in 2013 that specializes in neuroimaging data management, processing, visualization, and analysis for clinical trials, research, and diagnostic support. The platform serves biopharmaceutical companies, CROs, medical device manufacturers, academic institutions, and diagnostic centers. QMENTA's integrated infrastructure includes Smart Uploader with HIPAA-compliant PHI de-identification, secure cloud PACS connectivity with automated workflows, over 50 AI-powered imaging biomarkers, Central Review capabilities for remote collaboration, and an Imaging Management System with EDC and query management tools. The company has processed 13M+ imaging scans for 1M+ study participants across 250+ connected sites and completed 1M+ AI imaging analyses. Solutions address neurological diseases, oncology, and rare disease diagnostics with demonstrated cost reductions (50%) and reading time improvements (75%).

Gleamer is a Paris-based AI software company specializing in clinical-grade decision support and workflow automation for medical imaging. The company develops GleamerOS, a unified AI platform that orchestrates multiple deep learning models to enhance radiologist productivity and diagnostic accuracy across X-ray, CT, mammography, and other imaging modalities. Core offerings include BoneView (fracture detection and bone assessment), ChestView (urgent pulmonary findings), and Gleamer Copilot (comprehensive radiology AI suite with automated reporting, exam prioritization, and RIS integration). With deployment across 2,500+ clinical sites in 45+ countries, Gleamer has achieved significant clinical validation through 100+ international studies and 42+ peer-reviewed publications. The platform is designed for seamless integration into existing radiology workflows, reducing reading time and supporting 24/7 diagnostic support in emergency and routine settings.

Caristo Diagnostics is a cardiac imaging AI software company that develops proprietary technology to detect coronary inflammation and assess cardiovascular disease risk from coronary CT angiography (CCTA) imaging. The company's flagship platform, CaRi-Heart® Technology, combines AI-driven analysis with clinical cardiology to enable early detection of hidden inflammation associated with heart attack risk. Key product offerings include FAI-Score™ (Functional Assessment of Inflammation score for detecting coronary inflammation), CaRi-Plaque™ Analysis (quantifying and characterizing coronary plaque burden), and Individualised Risk Score (predicting cardiac events). Caristo serves multiple clinical applications: preventive screening for asymptomatic patients, disease diagnosis and risk stratification, drug clinical trials (as an imaging core lab), and intervention planning. The company has FDA 510(k) clearance, CPT code recognition from the American Medical Association, and demonstrated clinical utility through publications in The Lancet and presentations at major cardiology conferences (AHA, SCCT). Caristo operates imaging analysis centers globally and partners with leading pharmaceutical companies for atherosclerotic cardiovascular disease (ASCVD) trials. The company is positioned as a digital health innovator focused on transforming preventive cardiology through quantitative imaging biomarkers of coronary inflammation.

This is a test/demo listing used to verify the email-domain match in the claim flow. A user signing in with an @retailserviceproviders.com email should be redirected to /claim and offered the opportunity to claim this listing.

Blue Health International is a multi-service medical equipment provider operating across rental, distribution, and technical service channels. The company manages over 6,000 medical assets globally, serving more than 1,150 healthcare providers. Its core business units include: (1) Equipment Rental—offering new and pre-owned, multi-brand medical devices under Equipment-as-a-Service (EaaS) and traditional rental models with maintenance and SLA coverage for diagnostic imaging, life support, surgical equipment, and hospital furniture; (2) Distribution—exclusive and non-exclusive sales of new equipment, used units from internal stock, and consumables (reagents, needles, markers, contrast agents); and (3) Service—maintenance and remote monitoring solutions for MRI, CT, mammography, ultrasound, densitometry, and other diagnostic systems. The EaaS model emphasizes optimal capital allocation, outsourced equipment management, lower total cost of ownership, predictable cash flow, 24/7 technical support, and access to cutting-edge equipment lines. Blue Health maintains strategic partnerships with global manufacturers and emphasizes a 360° integration of technology, processes, and services. The company operates with a commitment to quality, sustainability, and supply chain responsibility, targeting healthcare providers seeking to optimize capital efficiency while maintaining high equipment availability and performance.

R.B. Enterprise, Inc. is a medical service company with over 25 years of experience specializing in maintenance, repair, and support for diagnostic imaging equipment. The company provides comprehensive service offerings including maintenance and service contracts, equipment refurbishing and upgrades, installations and de-installations, and supply and leasing solutions. Core competencies span MRI, CT, ultrasound, X-ray, C-arm fluoroscopy, and gamma camera systems, as well as imaging peripherals. R.B. Enterprise is known for specialized ultrasound probe repair capabilities, same-day response times, employment of professional licensed engineers, in-house latest technology infrastructure, and use of only original OEM parts. The company serves healthcare facilities requiring imaging equipment support and serves as a vendor for both routine maintenance contracts and emergency repair services.

Shining 3D Technology Inc develops high-accuracy 3D optical scanning and measurement solutions for metrology, engineering, digital dentistry, and specialized industrial applications. The company manufactures laser scanners, blue light 3D scanners, and handheld wireless scanning devices serving precision inspection, quality assurance, automotive, aerospace, orthopedic implant manufacturing, and dental laboratory workflows. Product lines include entry-level scanners (EINSTAR series), professional all-in-one systems (EinScan Rigil Series with tri-mode laser capability), metrology-grade standalone scanners (FreeScan Omni Series), high-precision inspection systems (OptimScan Q12/Q9), and robotic automation solutions (RobotScan Series). Digital dentistry offerings include intraoral and extraoral scanning systems for prosthodontics and implant planning. The company operates a 1,100 m² CNAS-accredited calibration and accuracy laboratory staffed by certified metrologists, adhering to VDI/VDE and ISO international standards. Core competencies include high-accuracy optical calibration technology, opto-mechatronic system design, real-time stereo reconstruction algorithms, and 3D geometric data processing software with customizable inspection modules. Founded in 2004, the company has sold over 100,000 units globally and maintains a reseller and trade-in program. Recipients of Red Dot Design Award 2024/2026, iF Design Award 2022/2026, and recognition as an emerging leader in metrology. Target markets include automotive manufacturing, civil aviation MRO, marine/boatbuilding, motorsports, healthcare (orthotics/prosthetics), and educational institutions.

Merative is a healthcare software and data analytics company offering integrated solutions across clinical imaging, data management, clinical decision support, and health services delivery. The company operates through five primary product lines: Merge (medical imaging and PACS solutions), Micromedex (evidence-based clinical decision support), Truven (healthcare data and analytics), Cúram (health and human services platform for benefits delivery and case management), and Zelta (cloud-based clinical trial data management). Merge provides enterprise imaging platforms, PACS systems, workflow orchestration, and imaging analytics serving 6 of 10 top U.S. health systems and 10 of 20 top U.S. hospitals across 5,500+ sites globally. Micromedex delivers medication-related clinical decision support used by healthcare providers for 40+ years. Truven serves 7 of 10 top U.S. payers and 40% of Fortune 100 employers with healthcare business intelligence and predictive analytics. Cúram supports 970+ social programs across government agencies, processing benefits for 187 million people globally with 200,000+ caseworker users. Zelta supports clinical development with 4,500+ studies across all phases including 500+ Phase III trials. The company serves healthcare systems, payers, employers, government agencies, pharmaceutical sponsors, CROs, and academic medical centers across 80+ countries. Products feature cloud-based deployment, workflow automation, real-world evidence integration, and interoperability with major healthcare IT systems.

United Medical Imaging Healthcare (UMIH) is a leading regional provider of diagnostic imaging services operating 32 full-service radiology facilities throughout Los Angeles and Orange Counties, California. The company serves over 300,000 patients annually through a comprehensive network delivering highly advanced diagnostic imaging solutions to referring physicians and healthcare partners. UMIH offers a broad spectrum of radiologic procedures including Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Positron Emission Tomography (PET), musculoskeletal imaging, breast imaging, and neuroradiological imaging. The company operates advanced imaging equipment including 3-Tesla MRI systems, 1.5-Tesla wide-bore and open MRI units (designed to accommodate claustrophobic or physically limited patients), and 128-slice CT scanners. Medical staff comprises specialty board-certified radiologists with expertise in musculoskeletal, breast, and neuroradiological imaging. UMIH emphasizes patient convenience and comfort, with same-day appointment availability and walk-in services at most locations, extended operating hours (7:30 AM–7 PM weekdays and Saturday appointments upon request), and culturally diverse, newly remodeled facilities. Diagnostic reports are typically delivered to referring physicians within 24–48 hours. The organization has operated for over two decades as an integrated provider of diagnostic imaging services in Southern California.

Alpha Imaging LLC is one of the largest medical imaging equipment distributors in the United States, serving hospitals, outpatient clinics, and private practice facilities. The company partners with leading global imaging manufacturers including Konica Minolta Healthcare, Shimadzu, Neusoft, KA Imaging, INTELLI-C, Sorna, Amrad Medical, Del Medical, and Integritech. Alpha Imaging distributes a broad portfolio of diagnostic imaging systems and solutions, with particular focus on multipurpose imaging platforms. The company describes itself as a fast-growing small business that delivers state-of-the-art imaging solutions to healthcare facilities across the United States. As a distributor rather than manufacturer, Alpha Imaging leverages partnerships with established OEMs to provide equipment, likely including radiography, fluoroscopy, and advanced imaging modalities. The company maintains sales consultation services and direct customer support channels to assist healthcare organizations in equipment procurement and deployment decisions.

Ecomed Solutions is a medical device company specializing in innovative, cost-effective products for healthcare providers and medical device manufacturers. The company operates as a contract manufacturer, private-label producer, and new product development partner for the medical device industry. Primary product lines include diagnostic imaging syringes compatible with leading injector systems (Mark V Plus, Mark V ProVis, Stellant), blood management solutions (HemaSavr line for reducing allogeneic transfusions), and maternal/neonatal wellness products (SureGlide line). The company serves healthcare systems, imaging centers, and OEM partners requiring high-quality medical consumables and specialized devices. Ecomed Solutions emphasizes quality, regulatory compliance, and patient care improvement across its product portfolio. The company offers end-to-end services including contract manufacturing with custom formulations, private-label manufacturing for partner brands, and collaborative new product development for emerging market needs.

Voiant is a clinical trial imaging Contract Research Organization (CRO) specializing in AI-powered imaging solutions for biopharmaceutical companies. With over 30 years of clinical expertise, Voiant delivers high-quality imaging endpoint data and endpoint adjudication services supporting therapies across oncology, ophthalmology, and respiratory indications from Phase I-IV global trials. The company operates a proprietary, purpose-built AI platform that accelerates imaging processing and analysis while maintaining scientific accuracy through expert human oversight. Voiant's services include independent reading center operations, blinded imaging review (BICR), and specialized imaging biomarker analysis. The company has expanded AI capabilities through acquisition of Voxeleron and maintains a global network of subspecialty-trained clinical readers, regulatory expertise, and over 2,700 registered clinical trial sites. Voiant has contributed to multiple FDA-approved therapies and serves as a trusted partner for sponsors, CROs, and clinical research organizations seeking reliable, reproducible imaging endpoint data and faster turnaround times.

Hologic, Inc. is a global medical technology company founded in 1985, headquartered in Redwood City, California, that specializes in diagnostics, surgical, and medical imaging technologies focused on women's health. The company develops and manufactures innovative platforms for the detection, diagnosis, and treatment of health conditions affecting women across all life stages, with particular expertise in breast health and cancer screening. Hologic's portfolio includes advanced mammography systems with integrated AI-powered detection technology, diagnostic devices, and surgical solutions. The company holds over 4,100 patents and operates in 36 countries with approximately 7,000 employees. Hologic's technology platforms emphasize early detection and proactive treatment to improve clinical outcomes and raise the standard of care globally. The company maintains regulatory compliance through FDA approvals and international certifications. In 2025, Hologic was acquired by Blackstone and TPG, becoming a privately held company. Hologic serves hospitals, imaging centers, diagnostic laboratories, and healthcare systems worldwide, with particular focus on women's preventive health, oncology, and reproductive health markets.

Universal Medical Resources (UMRI) is a specialized supplier of nuclear imaging systems, parts, and comprehensive support services. The company offers new gamma cameras engineered by X3D and expertly reconditioned nuclear imaging systems from major manufacturers including GE, Siemens, and Philips. Core product offerings include OEM new and reconditioned nuclear camera system parts from an extensive, thoroughly tested inventory designed to minimize returns and downtime. UMRI provides field-service support with trained biomedical engineers delivering fast response times and cost-effective preventive maintenance services, available 24/7 across the United States. The company specializes in system relocations, handling critical logistics for moving nuclear imaging equipment locally or nationally. UMRI delivers comprehensive classroom and hands-on training programs for clinical engineers, biomedical technicians, and nuclear medicine technologists, including continuing education and professional development. The company operates on core principles of collaboration with the nuclear medicine community, diversity of practices, excellence in quality outcomes, and ethical business conduct. UMRI rebuilds and replaces camera detectors and provides expert in-house technical support, positioning itself as a full-service partner for nuclear medicine departments seeking equipment, parts, maintenance, relocation, and workforce training solutions.

Double Black Imaging Corporation manufactures and integrates medical displays, monitors, and calibration software for diagnostic imaging, radiology, and surgical applications. Founded over 20 years ago, DBI specializes in PACS displays (3MP–12MP), mammography/tomosynthesis multi-modality monitors, surgical OR displays (26"–58"), clinical review displays, MR-Safe monitors, dental displays, and non-destructive testing (NDT) LED displays. The company develops proprietary DICOM calibration software (X-CAL® and CFS suites) and performs 100% display system integration and software development in the USA. DBI offers comprehensive product bundles including ergonomic workstations (66+ configurations), mounting solutions, CPUs, and DICOM laptops tailored for radiology departments and teleradiology operations. The company integrates LG Medical displays with proprietary calibration software under long-term licensing agreements. All displays are DICOM-calibrated and hospital-grade, backed by installation, training, and technical support. DBI serves radiology departments, surgical centers, dental practices, and imaging enterprises worldwide, emphasizing reliability, image quality stability, and cost reduction. The company maintains a track record of serving thousands of radiologists and IT professionals with industry-leading customer service.

MiE medical imaging electronics GmbH is a German manufacturer specializing in advanced nuclear medicine imaging systems, PET (Positron Emission Tomography), and SPECT (Single Photon Emission Computed Tomography) technologies. The company develops dedicated gamma camera systems and imaging workstations designed for precise molecular and diagnostic imaging in clinical and veterinary applications. MiE's product portfolio includes the ECAM NOVA, SYNGULA, and PICOLA gamma camera systems for SPECT, whole-body, and planar imaging procedures, alongside PET/CT imaging solutions such as the ANCORIS dedicated PET system and SCINTRON 7 for BIOGRAPH integration. The company also provides software upgrades and workstations for existing imaging platforms, as well as veterinary scintigraphy solutions for small and large animal imaging, including specialized equine scanning capabilities.

OcuSciences is an ophthalmic imaging company developing the OcuMet Beacon, a rapid and non-invasive ocular imager that utilizes OcuMet autofluorescence technology for detecting and monitoring eye diseases. The FDA-cleared device employs state-of-the-art optics to provide ophthalmologists and optometrists with functional retinal imaging capabilities. The technology enables fast, automated assessment of ocular pathology through endogenous autofluorescence measurement, assisting clinicians in disease detection and monitoring for conditions such as age-related macular degeneration (AMD), diabetic retinopathy, and glaucoma.

Imagen is an AI-enabled diagnostic imaging partner delivering teleradiology, on-site imaging equipment, and FDA-cleared AI software to independent practices, hospitals, and health systems nationally. The company operates a network of 95+ board-certified radiologists and sub-specialists across 50 states (active licenses), serving 3.5 million patients in 23 states. Core offerings include: (1) In-Clinic Imaging—permanent, in-office diagnostic imaging equipment with end-to-end support and program deployment; (2) AI-Enabled Interpretations—U.S.-based subspecialized clinicians augmented with proprietary FDA-cleared AI algorithms for improved diagnostic accuracy, consistency, and turnaround time; (3) Advanced Imaging Analytics (RadGap)—AI-driven image and report analytics for payers, providers, and risk-bearing entities to identify and close care gaps. The company positions itself as a partnership model between diagnosticians and ordering physicians, emphasizing 24/7 support, rapid turnaround, and clinical outcomes: 73% reduction in life-threatening misses (chest imaging), 100% improvement in chronic disease identification, and 97% all-time customer retention. Imagen manufactures or deploys diagnostic imaging hardware on-site and develops AI software for image interpretation and population health analytics. FDA clearances include AI algorithms; specific regulatory pathways (510(k), De Novo) not detailed in available content.

Cardea Technology develops BoneStation, an enterprise-class, web-based software solution for DXA-based bone densitometry reporting and workflow management. BoneStation streamlines operations for bone density practices and simplifies the interpretation of bone density scans for reading physicians and radiologists. Originally developed as a custom application for a major teaching hospital, BoneStation has been commercialized and is deployed at hospitals across the United States and Europe. The company specializes in medical software development with expertise in medical imaging integration, DICOM and HL7 standards, and cloud-based application architecture. Cardea leverages modern development technologies including Java, JavaScript, SQL, and cloud platforms (Google Cloud Platform and Amazon Web Services) to deliver responsive, data-driven healthcare applications. The company combines sound software engineering principles with practical, timely software delivery for healthcare clients.

Qisda Corporation is a global technology conglomerate founded in 1984, headquartered in Taiwan. The company operates across five major business segments: displays, projectors, medical devices, smart solutions, and networking services. In the medical sector, Qisda has developed a diversified medical fleet (醫療艦隊) encompassing six key domains: medical equipment, medical consumables, hemodialysis, medical imaging, health & wellness devices, and medical services. The company owns two large integrated hospitals and operates as both a medical device manufacturer and healthcare distribution provider. Qisda is recognized as a Thomson Reuters Global Tech 100 leader, an Asia Best Employer, and a Taiwan Top 10 Sustainability Enterprise. In displays, Qisda ranks as the world's second-largest LCD panel manufacturer, serving consumer, commercial, professional, and medical applications. In projectors, the company ranks in the global top three, holding the second-largest market share in DLP projection technology. The medical business serves first-line healthcare users with integrated solutions across hospital infrastructure, clinical diagnostics, renal therapy, imaging systems, consumer health products, and healthcare management services. Smart solutions span six verticals: smart retail, smart healthcare, smart energy, smart manufacturing, smart enterprise, and smart education, emphasizing hardware-software integration and one-stop provisioning. The networking division provides comprehensive broadband services including wired/wireless networks, broadband infrastructure, systems integration, and 5G enterprise private networks. Qisda operates manufacturing facilities and sales offices across 60+ countries with approximately 30,000 employees.

Ceevra is a medical software company that develops FDA-cleared machine learning and computer vision algorithms to generate detailed, interactive 3D digital models from CT and MRI imaging studies. The platform automatically processes imaging data without requiring manual input from hospital personnel and delivers 3D surgical visualization accessible on mobile devices, tablets, laptops, and integrated surgical robotic displays. Ceevra's 3D models are clinically validated to improve surgical planning and patient outcomes across multiple surgical specialties including thoracic, urologic, gynecologic, and general/hepatopancreaticobiliary (HPB) surgery. The solution supports open, laparoscopic, and robotic-assisted surgical approaches. Clinical evidence published in JAMA Network Open demonstrates significant improvements in surgical outcomes, including enhanced cancer control, functional preservation, and reduced adjuvant therapy rates in robotic urologic procedures. Ceevra serves major U.S. healthcare systems including UCLA Health, Mayo Clinic affiliates, Memorial Sloan Kettering, Baptist Health South Florida, and Tulane University School of Medicine. The company operates on a subscription model with implementation designed for rapid deployment across hospital networks.

Seno Medical Instruments develops the Imagio® Breast Imaging System, an opto-acoustic (photoacoustic) imaging platform for breast cancer diagnostics. The system combines light and sound technology to deliver real-time, functional diagnostic imaging that assesses breast masses for benign versus malignant characteristics in a single exam, without ionizing radiation. The company's flagship product is enhanced by SenoGram®, a proprietary AI-driven clinical decision support application designed to improve diagnostic accuracy and reduce false-positive biopsies. Imagio® addresses significant gaps in current breast imaging workflows by reducing diagnostic delays (median 34 days to diagnosis in standard pathways), minimizing unnecessary biopsies (50.4% false-positive rate in traditional screening), and improving patient experience. The system targets radiologists, imaging centers, and healthcare systems seeking to increase diagnostic confidence, streamline workflows, and reduce overall costs associated with inconclusive findings and repeat procedures. Seno Medical delivers training through its Seno University program to facilitate clinical integration. The technology leverages opto-acoustic principles—combining ultrasound and optical imaging—to visualize tissue morphology and functional properties. Clinical evidence supports the platform's ability to down-classify BI-RADS categories and reduce unnecessary interventions while maintaining cancer detection sensitivity.

Cision Vision is a medical technology company specializing in shortwave infrared (SWIR) imaging systems for pathology and surgical applications. Founded in 2020 as an MIT spinoff, the company's flagship InVision device provides label-free, real-time imaging that enhances lymph node identification and tissue grossing in laboratory and intraoperative settings. The technology leverages SWIR wavelengths (1000–2000 nm) to penetrate biological tissues deeply and provide natural contrast based on water and lipid content, eliminating the need for contrast agents or radiation. InVision has been recognized as one of Time Magazine's Best Inventions of 2023 and is deployed across multiple U.S. hospitals. The company's surgical application focuses on AI-powered critical structure identification during intraoperative guidance. Cision Vision has received significant government funding, including a prestigious ARPA-H award of up to $22.3 million as part of the Biden Cancer Moonshot initiative. The company collaborates with leading institutions including Johns Hopkins Medicine and Stanford Medicine, and operates the Visionary Program to support early-access initiatives for pathology innovators. Clinical validation includes a multicenter study published in the Journal of Clinical Pathology.

Springbok Analytics is an FDA-cleared medical device and software company specializing in advanced muscle health analytics derived from MRI imaging. The company develops AI-driven musculoskeletal analysis software that processes standard MRI scans to quantify individual muscle volume, fat infiltration, symmetry, and quality at pixel-level precision. Springbok serves three primary markets: (1) Research & Clinical Trials—accelerating muscle-related research with standardized, MRI-based quantification; (2) Elite Sports & Performance—tracking athlete muscle metrics for return-to-play and performance optimization (clients include NBA, NFL, Utah Jazz, DC United); and (3) Longevity & Preventive Health—objective tracking of muscle health over time for personalized health strategies. The platform analyzes over 100 individual muscles across legs, core, back, chest, shoulders, and arms, and can assess tendons, bone, scar tissue, and edema. Scans take 10–45 minutes to acquire; processing occurs within 24 hours, with detailed 3D visualizations and muscle-level data delivered via interactive web-based viewer within 2–3 days. The company is recognized for pioneering 3D musculoskeletal digital twin technology and was named a Fast Company Most Innovative Company in 2024. Regulatory clearance: FDA-cleared device.

Positrigo AG is a Swiss medical imaging company specializing in dedicated brain Positron Emission Tomography (PET) systems. The company manufactures the NeuroLF, an ultra-compact, fully integrated brain PET scanner designed to make functional neuroimaging accessible and affordable for precision medicine applications. The NeuroLF system is particularly focused on early diagnosis of neurodegenerative diseases, including Alzheimer's disease and other dementia-related disorders. The company has achieved FDA clearance (July 2024) and CE Mark (October 2024) for its NeuroLF system, enabling commercialization in the US and Europe. Positrigo holds ISO 13485:2016 certification, demonstrating compliance with medical device quality management standards. The company manufactures and distributes its systems through a network of international distributors across Europe, the US, and other regions. Recent deployments include installations at The Neuron Clinic (first US outpatient neurology clinic), Beverly Hills Medical Imaging, University Hospital of Genoa (Italy), and LMU Hospital Munich (Germany). Positrigo operates a US subsidiary established in 2023 and launched the BrainPET Accelerator program in the US to support clinical adoption. The company is backed by significant venture funding and has received grants from Innosuisse and the European Innovation Council (EIC Fund).

Delta Medical Systems is a Siemens Healthineers Advanced Partner providing premium medical imaging systems and comprehensive service solutions across the upper Midwest and Northeast United States. With over 45 years in the medical imaging industry, the company specializes in sales, installation, relocation, and ongoing support for imaging equipment across multiple clinical specialties including detection, diagnosis, pain management, surgery, and women's health. Delta's service-driven approach encompasses field service engineering, preventative maintenance, system upgrades, repairs, and clinical applications support. The company also offers short and long-term equipment rentals, business consulting, financial analysis, and marketing support for healthcare providers ranging from large health systems to rural clinics. All products are Siemens-branded imaging systems. Delta maintains a team of sales professionals, project managers, field service engineers, and clinical applications specialists focused on patient-centered solutions that reduce patient dose exposure while enhancing facility productivity and profitability.

Clarix Imaging Corp manufactures the VSI-360™ (Volumetric Specimen Imaging System), a specialized intraoperative imaging platform designed for breast surgical oncology. The system provides true 3D image reconstruction of lumpectomy specimens with high-resolution tissue slices, enabling surgeons to visualize specimen margins without tissue overlap during margin assessment. The technology emerged from decades of NIH-funded research at the University of Chicago and is designed to improve margin status interpretation and reduce the need for re-excision procedures. Clinical validation includes a 200-case retrospective study demonstrating sensitivity up to 94% and specificity up to 85% compared to traditional 2D specimen radiography and tomosynthesis. The system is deployed as a cart-based unit in operating rooms and enables rapid, high-quality isotropic 3D imaging to guide targeted shave margin excision. Clarix Imaging targets breast cancer surgical centers and academic medical centers with high lumpectomy case volumes (500+ cases annually). The company focuses on intraoperative specimen imaging for surgical oncology with emphasis on improving pathological margin assessment and patient outcomes by reducing revision surgeries.

CoLumbo is an FDA-cleared, CE-marked AI-powered diagnostic software platform that automates the analysis of lumbar spine MRI images. The platform uses advanced machine learning (fully convolutional neural networks with U-Net architecture) to perform pixel-level segmentation, detect spinal pathologies, quantify anatomical measurements, and generate customized diagnostic reports. CoLumbo reduces radiologist reporting time by 15–25%, decreases errors of omission by up to 15%, and improves diagnostic standardization across imaging centers. The solution serves multiple stakeholders: radiologists benefit from workflow efficiency and accuracy enhancement; surgeons gain structured anatomical insights for pre-surgical planning; and legal/insurance professionals obtain objective, standardized summaries of spinal imaging findings for personal injury case evaluation. Multi-language report generation and customizable pathology thresholds enable adaptation to institutional protocols. CoLumbo is deployed across European diagnostic imaging centers and integrated with major AI marketplace partners including Nuance, Sectra, Philips, and Harrison.ai.

Qynapse is a medical software company specializing in AI-powered neuroimaging analysis for central nervous system (CNS) diseases. The company develops advanced algorithms and software platforms that analyze MRI brain scans to provide automated biomarkers, diagnostic support, and disease monitoring capabilities for conditions including Alzheimer's disease, multiple sclerosis, and Parkinson's disease. QyScore® is Qynapse's flagship FDA-cleared (Class II) and CE-marked (Class IIa) software product designed for automatic labeling, visualization, and volumetric quantification of brain structures and lesions from MR images. The software provides volumetric data compared to reference percentile datasets and is intended to support clinicians in CNS disease diagnosis and monitoring. QyPredict® is a research-use-only platform combining genomics, biofluids, neuroimaging, cognitive endpoints, and activity measures to assess CNS disease trajectory. Qynapse addresses a critical clinical need: current CNS disease misdiagnosis rates reach approximately 30%, and the company reports diagnostic accuracy improvement from 66–70% to over 90%. The company serves healthcare providers, pharmaceutical researchers, payers, and patients/caregivers. Products are built on proprietary technology incorporating 20 algorithms and the company's proprietary normative dataset of over 10,000 brain scan images. Regulatory approvals include FDA clearance and CE marking; expansion into additional global markets is underway. The company's clinical advisory board includes leading neurology and radiology experts.

Wasatch Medical Specialties is the exclusive US distributor for the Boston Scientific cryoablation platform, specializing in mobile solutions for prostate cancer diagnosis and treatment. The company offers turnkey clinical services combining cutting-edge fusion biopsy equipment with helium-free cryoablation technology. Core offerings include the Visual-ICE Cryoablation System, a cryosurgical tool designed to destroy tissue through application of extremely cold temperatures, and MRI/Ultrasound fusion imaging systems that enable physicians to better target prostate cancer using advanced image guidance. Wasatch Medical Specialties serves healthcare providers seeking alternatives to backorder-delayed equipment and medical manufacturers exploring sales and distribution partnerships. The company operates as both a direct service provider (scheduling procedures and placing orders) and a distributor model, positioned to address clinical gaps in prostate cancer care through integrated diagnostic and interventional capabilities.

Elekta AB is a global leader in precision cancer care, specializing in radiotherapy and radiosurgery systems for oncology treatment. With over 50 years of experience, the company develops advanced solutions for adaptive radiotherapy—a precision treatment approach that adjusts to patient anatomy changes during therapy. Elekta's product portfolio includes linear accelerators for external beam radiotherapy, the Leksell Gamma Knife for stereotactic radiosurgery, and integrated imaging and software systems for treatment planning and guidance. The company serves cancer centers and hospitals worldwide, addressing multiple tumor types including head and neck, breast, prostate, brain, gynecological, kidney, and pancreatic cancers. Elekta's adaptive radiotherapy platform combines daily imaging, AI-assisted planning, and real-time treatment adjustment to optimize dose delivery while protecting healthy tissue. The company supports clinical workflows with comprehensive software solutions for treatment planning, image guidance, and outcome tracking. Elekta maintains a strong commitment to clinical evidence generation and supports leading oncology institutions globally. As a publicly traded company headquartered in Sweden, Elekta operates a global infrastructure including manufacturing, service centers, and training facilities. The organization emphasizes precision medicine innovation and advancing radiotherapy as a standard of care across diverse patient populations and healthcare settings.

MRIguidance develops BoneMRI, a medical imaging software solution that generates 3D CT-like images of bone structures derived from standard MRI scans. The technology eliminates the need for ionizing radiation exposure while providing diagnostic-quality bone visualization, eliminating duplicate imaging procedures and reducing patient hospital visits. BoneMRI integrates seamlessly with clinical workflows through automatic image reconstruction and PACS forwarding, compatible with major MRI scanner platforms from GE, Siemens, and Philips. The solution serves orthopedic surgery, spine surgery, and surgical navigation applications across cervical, thoracic, lumbar spine, and pelvic anatomies. Intended for adult, adolescent, and pediatric patient populations, BoneMRI supports diagnostic imaging, surgical navigation and planning, and research applications. The company holds trademark registrations in the US, UK, and EU. Recent product updates include stitching functionality and expanded scanner compatibility. Founded as a European company and operating a US entity, MRIguidance markets to academic medical centers and specialty surgical hospitals.

Sydney Neuroimaging Analysis Centre (SNAC) is an Australian neuroimaging research and clinical service provider integrating advanced AI, image analysis, and informatics solutions. Based at the University of Sydney's Brain and Mind Centre, SNAC operates a regulatory-compliant imaging analysis facility serving clinical trials, research, and clinical radiology workflows. Core service areas include: (1) Clinical Trials—Phase 2-4 central reading and image analysis for remyelinating therapies in Multiple Sclerosis, with full regulatory compliance and turnkey imaging support; (2) Neuroimaging AI—development and integration of artificial intelligence solutions for medical imaging in partnership with leading imaging device providers; (3) Imaging Informatics—software and consulting services including proprietary Torana platform for optimizing imaging workflows, data management, and operational efficiency; (4) Research Services—consulting for individual researchers and larger groups requiring neuroimaging expertise, biomarker development, and custom imaging pipelines; (5) Education & Training—tailored professional development in neuroimaging, deep learning, and AI technologies for radiologists, neurologists, imaging scientists, and trainees. SNAC emphasizes regulatory compliance, data privacy, and clinical integration of AI-enabled workflows. The company serves pharmaceutical trials, healthcare providers, research institutions, and imaging device manufacturers across Australia and internationally.

SimBioSys develops cloud-based AI and spatial biophysics software for precision cancer visualization, diagnosis, and treatment planning. The company's core technology combines artificial intelligence, spatial biophysics, and data science to segment tumors and create interactive 3D digital models from medical imaging (primarily DCE-MRI), addressing tumor heterogeneity beyond traditional 2D pathology. TumorSight Viz is the company's flagship product—FDA-cleared for breast cancer surgical planning and preoperative assessment. It transforms 2D MRI studies into 3D visualizations with volumetric calculations and anatomical measurements to support breast conservation decisions. Additional clinical solutions in development include TumorSight Plan (surgical guidance), TumorSight IQ (treatment response prediction), TumorSight Risk (recurrence risk assessment), TumorSight Marker (biomarker selection), and TumorSight Dose (therapeutic dosing). PhenoScope is a research platform supporting biomarker discovery, optimal dosing, combination therapy analysis, and indication expansion. The company serves breast surgeons, oncologists, academic medical centers, and biopharma researchers. Institutional partnerships include Baylor College of Medicine, NYU Langone Health, Yale Medicine, and NorthShore Health. The technology leverages NVIDIA infrastructure for 3D model generation. While TumorSight Viz holds FDA clearance, most advanced clinical applications remain investigational. SimBioSys positions itself at the intersection of precision medicine, surgical planning, and AI-driven oncology diagnostics.

Inter Medical USA LLC is a US-based distributor and service provider of nuclear medicine imaging systems engineered and designed in Germany. The company specializes in high-quality diagnostic nuclear medicine equipment, offering planar nuclear medicine systems, SPECT (Single Photon Emission Computed Tomography) installations, whole-body imaging systems, and specialized systems for neurological and cardiac diagnostics. Their product portfolio includes the UniCam line of gamma camera systems paired with Windows-based processing workstations featuring fully digital, highly integrated acquisition and analysis capabilities. Inter Medical USA provides DICOM-compatible recording and analysis software packages for nuclear medicine applications, including automated cardiac evaluation, image fusion, and PET/CT diagnosis tools designed to integrate seamlessly with existing PACS environments. The company emphasizes modern calibration algorithms for power, linearity, uniformity, and center-of-rotation optimization. Their clinical software solutions support comprehensive nuclear medicine workflows from image acquisition through diagnosis. Inter Medical USA markets its systems to hospital nuclear medicine departments, imaging centers, and clinical diagnostic facilities requiring reliable, cost-effective nuclear medicine imaging solutions with professional software support and workstation integration capabilities.

Konica Minolta is a diversified imaging technology company offering comprehensive healthcare IT and medical imaging solutions through its Healthcare Americas division. The company provides advanced digital imaging systems and integrated IT solutions that support the patient journey from diagnosis through treatment. Healthcare offerings include diagnostic imaging equipment, clinical software, and managed IT infrastructure services tailored to healthcare organizations. Beyond medical, Konica Minolta operates major business units in digital office printing, production and industrial printing, IT management services, measuring instruments for quality control, imaging IoT technology, textile printing, and security services. The company demonstrates significant R&D capabilities in optical and digital technologies, with manufacturing and service infrastructure supporting North American markets. Konica Minolta holds relevant certifications and regulatory approvals for medical device operations, though specific certifications are not detailed on the homepage. The organization serves enterprise and institutional clients across healthcare, printing, industrial, and technology sectors.

Aidoc is a healthcare AI software company founded in 2016, providing clinical decision support solutions built on its proprietary aiOS™ platform. The company delivers AI-powered medical imaging analysis and clinical intelligence tools across radiology, cardiology, neurovascular, and vascular care specialties. Aidoc's algorithms automatically analyze medical imaging (primarily CT scans) to detect acute pathologies, identify incidental findings, and prioritize critical cases for rapid clinical intervention. The platform integrates with hospital workflows to improve notification time-to-treatment, enhance care team coordination, and optimize patient management across departments. Serving over 1,600 medical centers globally and analyzing imaging for approximately 45 million patients annually, Aidoc enables healthcare systems to cover approximately 75% of their patient populations with AI-assisted clinical decision support. Key clinical applications include stroke detection and door-to-puncture time reduction, pulmonary embolism prioritization, cardiac disease measurement, and vascular pathology management.

Genus Medical Technologies is a Missouri-based healthcare supplier specializing in imaging contrast agents and related consumables. The company manufactures and distributes oral contrast media including VueBlu and Barium Sulfate (medium and high density formulations), power injector syringes, and contrast media products. Genus Medical serves hospitals, imaging centers, and physicians' clinics with a focus on nationwide distribution, clinical excellence, and cost-effective purchasing solutions. The company emphasizes product quality, variety, and supply chain efficiency to support diagnostic imaging workflows.

Shenzhen Beacon Display Technology Co., Ltd. is a national high-tech enterprise established in 2004, specializing in medical display technology and human-machine interface solutions for medical imaging. A subsidiary of Zhejiang Jingxin Pharmaceutical Co., Ltd., Beacon operates two R&D centers and three manufacturing bases with global support networks across Hong Kong, the Netherlands, Germany, France, the USA, and South Korea. The company manufactures DICOM-standard medical-grade displays, diagnostic workstations, and 3D post-processing systems for radiological, pathological, and surgical imaging applications. Beacon serves as a strategic ODM partner for leading medical equipment manufacturers, with products deployed across 8,000+ hospital users worldwide in over 100 countries. The product portfolio includes intelligent displays, integrated human-machine interfaces, and customized diagnostic and surgical imaging solutions. With 21 years of R&D and manufacturing experience, Beacon holds significant market share in China and maintains partnerships with 95% of global leading medical device manufacturers.

IONIC Health is a health-tech company specializing in automation, integration, and remote operation technologies for diagnostic medicine, particularly medical imaging. Founded in 2019 with headquarters in São José dos Campos, Brazil, and offices in Cleveland, Ohio and Portugal, IONIC Health serves over 90 B2B clients globally, including major diagnostic centers and hospital networks. The company provides comprehensive software and digital solutions designed to improve efficiency, safety, and accessibility in diagnostic imaging workflows. Key offerings include remote teleoperation platforms for imaging devices (MRI, CT, ultrasound), real-time equipment monitoring and analytics, AI-powered structured radiology reporting with speech recognition, and end-to-end integration solutions. IONIC Health leverages advanced technologies including artificial intelligence, machine learning, big data analytics, and voice recognition to enable remote scanning, automated workflows, and intelligent decision support. With CE Mark approval and ISO/IEC 27001 certification, IONIC Health has demonstrated measurable impact: over 1 million exams facilitated, 1 million+ medical reports issued, 300+ devices under teleoperation, and documented customer savings exceeding $20 million. The company serves a diverse network of over 2,500 physicians and continues expanding across Latin America, Europe, and North America.

TeraRecon, Inc. is a healthcare software company specializing in AI-powered advanced medical imaging visualization and enterprise image management solutions. The company delivers SaaS-based platforms—TeraRecon AV (registered as Intuition globally) and TeraRecon DETECT—that combine advanced 3D visualization with AI-driven automation to enhance diagnostic precision and clinical workflow efficiency. Products support radiology, cardiology, neurology, vascular surgery, and oncology applications with features including medical image viewing, AI biomarker detection, real-time decision support, and enterprise imaging consolidation. Founded in 1997 and based in Durham, North Carolina, TeraRecon serves approximately 1,900 clinical sites globally with ~195-244 employees and ~$41M annual revenue. The platform emphasizes interoperability, enabling integration with existing hospital imaging systems while automating routine interpretation tasks and reducing clinician time-to-diagnosis.

Foresight Imaging is an OEM manufacturer of high-performance video capture boards and PACS connectivity solutions for medical and defense imaging applications. ISO 13485 certified, the company has produced over 100,000 imaging boards in use at elite medical centers worldwide. Foresight Imaging specializes in high-accuracy video streamers and frame grabbers supporting multiple video signal types (HDMI, DVI, SDI, monochrome, RGB, analog, standard and non-standard formats) with sustained transfer rates up to 1.3 GB/second and advanced signal processing (±0.5 ns pixel jitter, 59 dB signal-to-noise ratio, 10-bit A/D conversion). The company's TIMS platform is a 510(k)-accredited analog-to-DICOM workstation solution combining image acquisition software with telemedicine capabilities for remote diagnostics. Applications include surgical recording, angiography, OCT, ultrasound imaging, and specialized medical visualization. Foresight provides comprehensive OEM support including software development kits (C libraries, DirectShow drivers, example programs in .NET, C++, Linux), technical engineering support during development, and automated configuration tools.

Trivitron Healthcare is a Chennai-based private medical technology company established in 1997, operating across 180+ countries with 15 USFDA- and CE-certified manufacturing facilities. The company specializes in integrated healthcare solutions spanning medical imaging, in-vitro diagnostics (IVD), newborn screening, radiation protection, critical care equipment, renal care solutions, and operating room systems. Trivitron delivers comprehensive turnkey healthcare solutions including facility design, equipment procurement, installation, and ongoing maintenance support. The company operates modern laboratory platforms for high-throughput automated diagnostics, portable screening systems for early disease detection in resource-limited settings, patient monitoring and ventilation systems for ICU environments, and AI-enhanced imaging analytics. With over 100,000 customers including hospitals, clinics, and laboratories globally, Trivitron focuses on making quality healthcare accessible and affordable in underserved regions, particularly across Africa and developing economies.

Mediso Medical Imaging Systems is a Budapest-based leader in nuclear and molecular imaging since 1990, developing, manufacturing, and servicing advanced imaging systems for both clinical patient care and preclinical research. The company operates over 1,400 clinical and 350 preclinical systems across more than 100 countries. The clinical product platform, AnyScan®, delivers multi-level nuclear medicine imaging systems including gamma cameras, SPECT, SPECT/CT, and integrated SPECT/CT/PET configurations with unified graphical user interface and multimodality image reconstruction software. Preclinical offerings include the nanoScan® family, featuring high-end small-animal imaging with PET, SPECT, CT, and cryogen-free MRI (3T, 7T) capabilities. Mediso provides FDA-approved InterView™ multimodality image processing and reporting software, clinical training services, and comprehensive support for hospitals, research institutions, and clinics worldwide.

Monitors.com (Bayland Technologies, Inc.) is a specialized B2B supplier of diagnostic radiology displays and PACS workstations based in Houston, Texas. With 13+ years of experience, the company sources, delivers, installs, and services medical-grade radiology monitors and complete reading stations for radiology practices, imaging centers, and hospitals worldwide. Monitors.com offers an extensive portfolio of DICOM-calibrated diagnostic displays from premium manufacturers including Barco (Nio, Coronis, Eonis), LG, and Eizo—ranging from 2MP clinical review monitors to 12MP mammography tomosynthesis displays. The company also supplies high-performance radiology workstations (Lenovo ThinkStation, HP Z-series, Dell ProMax) pre-configured with medical-grade graphics cards (Barco MXRT), and complete turnkey PACS reading stations bundled with monitors, workstations, dictation systems, and worklist displays. Monitors.com provides in-house technical support, repair, and calibration services with 48-hour turnaround, ensuring compliance with FDA and clinical standards. The company serves diagnostic radiology, mammography, general imaging, and subspecialty radiology workflows.

Imeka Solutions Inc. is a Canadian medical software company specializing in advanced brain imaging analysis and neuroinflammation assessment. Founded in 2011 as a spinoff from the University of Sherbrooke, the company develops AI-powered diffusion MRI analysis tools for clinical neurology and pharmaceutical research. ANDI (Advanced Neuro Diagnostic Imaging) is an FDA 510(k)-cleared medical device software that quantifies white matter microstructure, axonal integrity, and myelin health to support diagnostics and monitoring of neurodegenerative diseases including Alzheimer's disease, multiple sclerosis, Parkinson's disease, and traumatic brain injury. The platform automates DTI (Diffusion Tensor Imaging) processing and provides comprehensive clinical reports for neurologists and researchers. Imeka serves clinicians, academic medical centers, and pharmaceutical companies developing neurotherapeutics, with strategic partnerships across North America, Europe, and Asia.